AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32592003 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning‐based computer‐aided diagnosis (CAD) system
Number of subjects: 120
Study 32592003 — intervention group
Group type: COMPARATOR
Intervention: Radiologists without CAD
Number of subjects: 120
Study 34368886 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured education program including appearance management and mind control for 4 weeks
Number of subjects: 109
Study 32573396 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright light therapy (light monotherapy)
Number of subjects: 119
Study 32573396 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (fluoxetine monotherapy)
Number of subjects: 119
Study 32573396 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of bright light therapy and fluoxetine
Number of subjects: 119
Study 32573396 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119
Study 33205201 — intervention group
Group type: EXPERIMENTAL
Intervention: ensoETM device (oesophageal temperature control device) maintaining luminal temperature at 4°C during RF ablation
Number of subjects: 188
Study 33205201 — intervention group
Group type: COMPARATOR
Intervention: Standard practice utilizing a single-point temperature probe (control group)
Number of subjects: 188
Study 33205201 — intervention group
Group type: EXPERIMENTAL
Intervention: ensoETM device
Number of subjects: 188
Study 33205201 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 188
Study 32040875 — intervention group
Group type: EXPERIMENTAL
Intervention: Atraumatic Restorative Treatment and Hall Technique (ART/HT)
Number of subjects: 65
Study 32040875 — intervention group
Group type: COMPARATOR
Intervention: Dental General Anaesthesia (DGA)
Number of subjects: 65
Study 32040875 — intervention group
Group type: EXPERIMENTAL
Intervention: Crown restorations
Number of subjects: 65
Study 35637038 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical Cannabidiol (CBD) 6.2 mg/mL with shea butter, applied twice daily for 2 weeks
Number of subjects: 18
Study 35637038 — intervention group
Group type: COMPARATOR
Intervention: Control: Shea butter alone, applied twice daily for 2 weeks
Number of subjects: 18
Study 33546679 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-directed learning by video (SDL-V)
Number of subjects: 22
Study 33546679 — intervention group
Group type: COMPARATOR
Intervention: Control group (regular duties)
Number of subjects: 22
Study 33546679 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (SDL-V and Control)
Number of subjects: 22
Study 32111479 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant formulation (n = 85) containing 500 mg of vitamin C, 400 mg of vitamin E, 0.20 mg of selenium, 1,000 mg of l-carnitine, 20 mg of zinc, 1,000 μg of folic acid, 10 mg of lycopene daily
Number of subjects: 174
Study 32111479 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 86)
Number of subjects: 174
Study 32111479 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant formulation
Number of subjects: 174
Study 32111479 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 174
Study 36017151 — intervention group
Group type: EXPERIMENTAL
Intervention: SEMS placement time = 14 days (n = 19 patients)
Number of subjects: 64
Study 36017151 — intervention group
Group type: COMPARATOR
Intervention: SEMS placement time > 14 days (n = 45 patients)
Number of subjects: 64
Study 33987881 — intervention group
Group type: EXPERIMENTAL
Intervention: Tonic painful pressure applied to the non-dominant leg during induction of referred pain (conditioning session)
Number of subjects: 24
Study 33987881 — intervention group
Group type: COMPARATOR
Intervention: Control session with no conditioning stimulus
Number of subjects: 24
Study 34391309 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-Body Vibration (WBV) therapy, 12 sessions, amplitude of 3 mm, frequency of 20 Hz, 6 days/week for 2 weeks
Number of subjects: 64
Study 34391309 — intervention group
Group type: COMPARATOR
Intervention: Routine Physiotherapy (RP)
Number of subjects: 64
Study 33320101 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearable devices, health management platform, and social media support
Number of subjects: 60
Study 32216204 — intervention group
Group type: EXPERIMENTAL
Intervention: Yishen Zhuangyang Cream (YZC)
Number of subjects: 92
Study 32216204 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 92
Study 33595105 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D CNN model for pancreas segmentation at full dose CT
Number of subjects: 1917
Study 33595105 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D CNN model for pancreas segmentation at reduced dose CT
Number of subjects: 1917
Study 33595105 — intervention group
Group type: COMPARATOR
Intervention: 3D CNN model vs R1 at full dose CT
Number of subjects: 1917
Study 33595105 — intervention group
Group type: COMPARATOR
Intervention: 3D CNN model vs R2 at full dose CT
Number of subjects: 1917
Study 33595105 — intervention group
Group type: COMPARATOR
Intervention: 3D CNN model vs R1 at reduced dose CT
Number of subjects: 1917
Study 33595105 — intervention group
Group type: COMPARATOR
Intervention: 3D CNN model vs R2 at reduced dose CT
Number of subjects: 1917
Study 33595105 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D CNN model on NIH-PCT dataset
Number of subjects: 1917
Study 32322324 — intervention group
Group type: EXPERIMENTAL
Intervention: R‐EBUS‐guided transbronchial lung biopsy (TBLB)
Number of subjects: 121
Study 32322324 — intervention group
Group type: COMPARATOR
Intervention: Transbronchial lung biopsy (TBLB)
Number of subjects: 121
Study 36370703 — intervention group
Group type: EXPERIMENTAL
Intervention: Brain Endurance Training (BET)
Number of subjects: 22
Study 36370703 — intervention group
Group type: COMPARATOR
Intervention: Control (listening to neutral sounds)
Number of subjects: 22
Study 34373322 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.45% sodium chloride fluids
Number of subjects: 1251
Study 34373322 — intervention group
Group type: COMPARATOR
Intervention: 0.9% sodium chloride fluids
Number of subjects: 1251
Study 34373322 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher rates of fluid infusion
Number of subjects: 1251
Study 36288782 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyson high‐efficiency particulate air air purifier
Number of subjects: 50
Study 36288782 — intervention group
Group type: COMPARATOR
Intervention: Dummy filters (placebo)
Number of subjects: 50
Study 34413362 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifocal glasses (add +2.5 Dioptres; n=50)
Number of subjects: 102
Study 34413362 — intervention group
Group type: COMPARATOR
Intervention: Unifocal glasses (n=52)
Number of subjects: 102
Study 34413362 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifocal glasses (n=50)
Number of subjects: 102
Study 32306925 — intervention group
Group type: EXPERIMENTAL
Intervention: Return-to-work (RTW) intervention provided by RTW experts in intervention wards.
Number of subjects: 200
Study 32306925 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU) in control wards.
Number of subjects: 200
Study 33320223 — intervention group
Group type: EXPERIMENTAL
Intervention: Aflibercept (100 participants)
Number of subjects: 205
Study 33320223 — intervention group
Group type: COMPARATOR
Intervention: Vitrectomy with panretinal photocoagulation (105 participants)
Number of subjects: 205
Study 36381249 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab biosimilar (LY06006) 60 mg subcutaneously every 6 months for 1 year
Number of subjects: 448
Study 36381249 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab biosimilar (LY06006)
Number of subjects: 448
Study 36381249 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 448
Study 34397702 — intervention group
Group type: EXPERIMENTAL
Intervention: Growtropin‐II (recombinant human GH)
Number of subjects: 75
Study 34397702 — intervention group
Group type: COMPARATOR
Intervention: Genotropin
Number of subjects: 75
Study 34397702 — intervention group
Group type: COMPARATOR
Intervention: Non-treatment group
Number of subjects: 75
Study 34397702 — intervention group
Group type: EXPERIMENTAL
Intervention: Growtropin‐II
Number of subjects: 75
Study 34397702 — intervention group
Group type: EXPERIMENTAL
Intervention: Growtropin‐II and Genotropin
Number of subjects: 75
Study 32957414 — intervention group
Group type: EXPERIMENTAL
Intervention: Hachimijiogan (HJG)
Number of subjects: 86
Study 32957414 — intervention group
Group type: COMPARATOR
Intervention: Control group (no additional HJG)
Number of subjects: 86
Study 34852379 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg daily aspirin
Number of subjects: 13547
Study 34852379 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13547
Study 33573699 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose intravenous vitamin C (HDIVC) 6 g daily
Number of subjects: 60
Study 33573699 — intervention group
Group type: COMPARATOR
Intervention: Lopinavir/ritonavir and hydroxychloroquine (Control)
Number of subjects: 60
Study 33753853 — intervention group
Group type: EXPERIMENTAL
Intervention: Active transcranial direct-current stimulation (a‐tDCS) at 2 mA for 20 min
Number of subjects: 100
Study 33753853 — intervention group
Group type: COMPARATOR
Intervention: Sham transcranial direct-current stimulation (s‐tDCS)
Number of subjects: 100
Study 33753853 — intervention group
Group type: EXPERIMENTAL
Intervention: Active transcranial direct-current stimulation (a‐tDCS)
Number of subjects: 100
Study 32201622 — intervention group
Group type: EXPERIMENTAL
Intervention: Women for Women International (WfWI) economic and social empowerment programme
Number of subjects: 1461
Study 35140880 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based Tai Chi Chuan (MTCC)
Number of subjects: 59
Study 33687463 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventral surgery
Number of subjects: 163
Study 33687463 — intervention group
Group type: COMPARATOR
Intervention: Dorsal surgery
Number of subjects: 163
Study 34100922 — intervention group
Group type: EXPERIMENTAL
Intervention: Apremilast 30 mg
Number of subjects: 527
Study 34100922 — intervention group
Group type: EXPERIMENTAL
Intervention: Apremilast 20 mg
Number of subjects: 527
Study 34100922 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 527
Study 32623947 — intervention group
Group type: EXPERIMENTAL
Intervention: Responsive group (n = 45)
Number of subjects: 265
Study 32623947 — intervention group
Group type: EXPERIMENTAL
Intervention: Mildly responsive group (n = 109)
Number of subjects: 265
Study 32623947 — intervention group
Group type: EXPERIMENTAL
Intervention: Mildly non-responsive group (n = 90)
Number of subjects: 265
Study 32623947 — intervention group
Group type: EXPERIMENTAL
Intervention: Strongly non-responsive group (n = 21)
Number of subjects: 265
Study 32623947 — intervention group
Group type: COMPARATOR
Intervention: Responsive groups vs Non-responsive groups
Number of subjects: 265
Study 32623947 — intervention group
Group type: COMPARATOR
Intervention: Mildly non-responsive group vs Strongly non-responsive group
Number of subjects: 265
Study 36334963 — intervention group
Group type: EXPERIMENTAL
Intervention: Conferoport (generic ER-Tac)
Number of subjects: 52
Study 36334963 — intervention group
Group type: COMPARATOR
Intervention: Advagraf (reference brand ER-Tac)
Number of subjects: 52
Study 36334963 — intervention group
Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 52
Study 32333486 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance-based group behavioral therapy (ABBT)
Number of subjects: 92
Study 32333486 — intervention group
Group type: COMPARATOR
Intervention: Standard nondirective supportive group therapy (NDST)
Number of subjects: 92
Study 35524376 — intervention group
Group type: EXPERIMENTAL
Intervention: Krocina™
Number of subjects: 80
Study 35524376 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 32937273 — intervention group
Group type: EXPERIMENTAL
Intervention: Ankle bandaging
Number of subjects: 100
Study 32937273 — intervention group
Group type: EXPERIMENTAL
Intervention: Ankle taping
Number of subjects: 100
Study 32937273 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo taping)
Number of subjects: 100
Study 36889873 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily remote monitoring data
Number of subjects: 2718
Study 36889873 — intervention group
Group type: EXPERIMENTAL
Intervention: Neural network modeling
Number of subjects: 2718
Study 32383227 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Nicotinamide (NAM) supplementation
Number of subjects: 0
Study 32383227 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 35970102 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFOX plus panitumumab
Number of subjects: 106
Study 35970102 — intervention group
Group type: COMPARATOR
Intervention: FOLFOX (control)
Number of subjects: 106
Study 34386892 — intervention group
Group type: EXPERIMENTAL
Intervention: FemoSeal® (FS)
Number of subjects: 230
Study 34386892 — intervention group
Group type: COMPARATOR
Intervention: ProGlide® (PG)
Number of subjects: 230
Study 34562564 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose Guizhi Fuling Wan
Number of subjects: 78
Study 34562564 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional-dose Guizhi Fuling Wan
Number of subjects: 78
Study 34562564 — intervention group
Group type: COMPARATOR
Intervention: Sub-effective dose control (not explicitly named)
Number of subjects: 78
Study 32986364 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoke-Free Policy (SFP) compliance criteria
Number of subjects: 105
Study 36375708 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozonated water (OZW) mouthwash
Number of subjects: 73
Study 36375708 — intervention group
Group type: COMPARATOR
Intervention: Chlorhexidine (CHG) mouthwash
Number of subjects: 73
Study 33399376 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep neuromuscular blockade (Deep NMB)
Number of subjects: 82
Study 33399376 — intervention group
Group type: COMPARATOR
Intervention: Moderate neuromuscular blockade (Mod NMB)
Number of subjects: 82
Study 32739846 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical capsaicin
Number of subjects: 136
Study 32739846 — intervention group
Group type: COMPARATOR
Intervention: Topical piroxicam
Number of subjects: 136
Study 36082065 — intervention group
Group type: EXPERIMENTAL
Intervention: ERAS concept combined with self‐made raising leg pad nursing
Number of subjects: 98
Study 36082065 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing intervention
Number of subjects: 98
Study 32845223 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic staplers (n = 26)
Number of subjects: 51
Study 32845223 — intervention group
Group type: COMPARATOR
Intervention: Vessel sealing device (Ligasure) (n = 25)
Number of subjects: 51
Study 32106339 — intervention group
Group type: EXPERIMENTAL
Intervention: DS-1040 with multiple-dose aspirin
Number of subjects: 0
Study 32106339 — intervention group
Group type: EXPERIMENTAL
Intervention: DS-1040 with multiple-dose clopidogrel
Number of subjects: 0
Study 32106339 — intervention group
Group type: EXPERIMENTAL
Intervention: DS-1040 with single-dose enoxaparin
Number of subjects: 0
Study 35688920 — intervention group
Group type: EXPERIMENTAL
Intervention: Estimation formula for tourniquet pressure (TP) based on thigh circumferences and systolic blood pressure (SBP)
Number of subjects: 3
Study 35688920 — intervention group
Group type: COMPARATOR
Intervention: SBP plus 100 mmHg
Number of subjects: 3
Study 35688920 — intervention group
Group type: COMPARATOR
Intervention: Fixed value of 300 mmHg
Number of subjects: 3
Study 35688920 — intervention group
Group type: EXPERIMENTAL
Intervention: Estimation method for TP
Number of subjects: 3
Study 34434003 — intervention group
Group type: EXPERIMENTAL
Intervention: BMAC injection followed by PRP injection
Number of subjects: 0
Study 34434003 — intervention group
Group type: COMPARATOR
Intervention: Gel-One® cross-linked hyaluronate (HA) injection
Number of subjects: 0
Study 32445557 — intervention group
Group type: EXPERIMENTAL
Intervention: MG+SG (compression with foam roller/ball + static stretching)
Number of subjects: 80
Study 32445557 — intervention group
Group type: EXPERIMENTAL
Intervention: MG (compression only)
Number of subjects: 80
Study 32445557 — intervention group
Group type: EXPERIMENTAL
Intervention: SG (static stretching only)
Number of subjects: 80
Study 32445557 — intervention group
Group type: COMPARATOR
Intervention: CG (control group, no intervention)
Number of subjects: 80
Study 35958675 — intervention group
Group type: EXPERIMENTAL
Intervention: Patellar taping and EMG‐BF‐guided isometric contraction exercise at 30°, 60°, and 90° angles
Number of subjects: 60
Study 35958675 — intervention group
Group type: COMPARATOR
Intervention: Sham patellar taping without EMG‐BF‐guided exercises
Number of subjects: 60
Study 33763732 — intervention group
Group type: EXPERIMENTAL
Intervention: MSON (ON-affected eyes of MS patients)
Number of subjects: 20
Study 33763732 — intervention group
Group type: EXPERIMENTAL
Intervention: MSNON (fellow healthy eyes of MS patients)
Number of subjects: 20
Study 33763732 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 20
Study 33763732 — intervention group
Group type: EXPERIMENTAL
Intervention: MSON
Number of subjects: 20
Study 33763732 — intervention group
Group type: EXPERIMENTAL
Intervention: MSNON
Number of subjects: 20
Study 32883279 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-support lifestyle intervention (12-month duration, 15 group sessions in community settings)
Number of subjects: 1007
Study 32883279 — intervention group
Group type: COMPARATOR
Intervention: Control group received a booklet on lifestyle change
Number of subjects: 1007
Study 35049354 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated insulin delivery (AID)
Number of subjects: 14
Study 35049354 — intervention group
Group type: COMPARATOR
Intervention: Sensor-augmented pump (SAP)
Number of subjects: 14
Study 33784580 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary simulation team training
Number of subjects: 10
Study 34924557 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-based lifestyle weight loss intervention
Number of subjects: 280
Study 34924557 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 280
Study 33167568 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole genome sequencing of porcine astroviruses from piglets
Number of subjects: 446
Study 33167568 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombination analysis of PoAstV4
Number of subjects: 446
Study 33167568 — intervention group
Group type: EXPERIMENTAL
Intervention: Linear antigen epitope prediction and comparative analysis of capsid protein
Number of subjects: 446
Study 34981778 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained oral peanut protein exposure
Number of subjects: 0
Study 34981778 — intervention group
Group type: COMPARATOR
Intervention: Cessation of peanut consumption
Number of subjects: 0
Study 34981778 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of HLA-DQA1*01:02
Number of subjects: 0
Study 34981778 — intervention group
Group type: COMPARATOR
Intervention: Absence of oral peanut protein exposure
Number of subjects: 0
Study 32666822 — intervention group
Group type: EXPERIMENTAL
Intervention: Androgen deprivation therapy (ADT) for 24 months
Number of subjects: 0
Study 32666822 — intervention group
Group type: COMPARATOR
Intervention: Androgen deprivation therapy (ADT) for 6 months
Number of subjects: 0
Study 33476409 — intervention group
Group type: EXPERIMENTAL
Intervention: HIMV (high intended movement velocity)
Number of subjects: 20
Study 33476409 — intervention group
Group type: COMPARATOR
Intervention: TRAD (traditional training)
Number of subjects: 20
Study 32912546 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam for seven days post-operatively
Number of subjects: 76
Study 32912546 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone (no levetiracetam)
Number of subjects: 76
Study 32912546 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 76
Study 34924372 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus paracasei releasing Ang-(1-7) (LP-A)
Number of subjects: 0
Study 34924372 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus paracasei (LP)
Number of subjects: 0
Study 34924372 — intervention group
Group type: COMPARATOR
Intervention: Sucrose
Number of subjects: 0
Study 33073963 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregnant patients with metabolic syndrome (MS)
Number of subjects: 62
Study 35671671 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiloride
Number of subjects: 445
Study 35671671 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 445
Study 35671671 — intervention group
Group type: EXPERIMENTAL
Intervention: Riluzole
Number of subjects: 445
Study 35671671 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 445
Study 32669487 — intervention group
Group type: COMPARATOR
Intervention: Stretch group (hip muscle stretching exercises)
Number of subjects: 66
Study 32669487 — intervention group
Group type: COMPARATOR
Intervention: Strengthen group (hip muscle strengthening exercises)
Number of subjects: 66
Study 32669487 — intervention group
Group type: EXPERIMENTAL
Intervention: Sham group (gentle palpation of the skin)
Number of subjects: 66
Study 34425223 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg once daily
Number of subjects: 55
Study 34425223 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 35022147 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative‐Pressure Wound Therapy (NPWT)
Number of subjects: 30
Study 35022147 — intervention group
Group type: COMPARATOR
Intervention: Wet‐to‐dry dressing
Number of subjects: 30
Study 36137919 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthokeratology lens wear
Number of subjects: 50
Study 32969513 — intervention group
Group type: EXPERIMENTAL
Intervention: Laplace-based algorithm for treatment allocation
Number of subjects: 0
Study 32969513 — intervention group
Group type: COMPARATOR
Intervention: Multiarmed bandit approach
Number of subjects: 0
Study 32969513 — intervention group
Group type: COMPARATOR
Intervention: Randomized N-of-1 trial design
Number of subjects: 0
Study 34249850 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital or face-to-face alcohol prevention intervention
Number of subjects: 779
Study 34249850 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 779
Study 34249850 — intervention group
Group type: EXPERIMENTAL
Intervention: Willing employees
Number of subjects: 779